see web site
look for retracement to $70-72 area in near term
This Stock's Chart is Screaming Oversold -- Go Long Now!
Share on facebookShare on twitterShare on emailShare on print
By Jared Levy on September 12, 2014
When a stock reaches oversold levels on the charts without any discernable fundamental reason for doing so, a bullish opportunity often presents itself. That is the case with today's trade, Penske Automotive Group (NYSE: PAG).
The stock is 15% off its July 7 high, and not only has there been a lack of bearish news, the news has been downright bullish.
The second-largest auto dealership group in the United States announced a 5% increase in its quarterly dividend to $0.20 per share in mid-July.
Two weeks later, it reported record quarterly profits, with income from continuing operations increasing 28% from the year-ago quarter to $80.3 million. Earnings per share (EPS) jumped 27% to $0.89, beating consensus estimates by $0.02.
Analysts have steadily increased their full-year earnings projections. They now stand at $3.27 per share for 2014, up from $3.18 three months ago. And 2015 EPS estimates have risen to $3.64 from $3.53 in the past 90 days.
The mean consensus target for the stock is $53.67, more than 20% above the recent price, and no analysts currently have a "sell" rating on the shares.
So, with fundamentals bullish, we turn to the chart where several indicators are screaming oversold.
Piper Jaffray upgraded Under Armour, Inc. (NYSE: UA) from Neutral to Overweight with a price target of $78.00 (from $63.00) after transitioning coverage.
Analyst Erinn Murphy said, "... the company is poised to continue to see significant market share gains across the board with particular areas of emphasis in women's, footwear and international supporting a market cap that can at least double over time. We believe the Fall season has started particularly strong with building momentum in women's and international. While we are maintaining our FY14 estimates, we believe they are conservative. We are increasing our FY15 EPS from $1.15 to $1.20 and believe that over time, EPS power of $3.50 is achievable."
in addition to stock being overbought on technicals
taking profits and moving on...look for continued pullback in coming days to 36-37 support area
Shares of Las Vegas Sands Corp. (NYSE:LVS) have received an average rating of “Buy” from the twenty-three ratings firms that are covering the stock, Analyst Ratings News reports. Five research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $82.57.
seems like insiders are bailing out , but shareholders be left holding the bag at the TOP :)
SVP James Kevin Scott sold 2,187 shares of the stock on the open market in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $217.27, for a total transaction of $475,169.49.
LinkedIn Corp SVP Unloads $2,193,500 in Stock (LNKD)
August 21st, 2014 - Michael Gamson sold 10,000 shares of LinkedIn Corp stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $219.35, for a total value of $2,193,500.00.
CAO Susan J.S. Taylor unloaded 1,672 shares of LinkedIn Corp stock on the open market in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $216.22, for a total transaction of $361,519.84. Following the transaction, the chief accounting officer now directly owns 10,158 shares in the company
CEO Jeff Weiner sold 31,741 shares of LinkedIn Corp stock on the open market in a transaction dated Monday, August 18th. The stock was sold at an average price of $218.53, for a total transaction of $6,936,360.73.
LinkedIn Corp (NYSE:LNKD) CFO Steven J. Sordello sold 3,014 shares of LinkedIn Corp stock on the open market in a transaction dated Monday, August 18th. The stock was sold at an average price of $216.37, for a total transaction of $652,139.18
Accelerate Diagnostics Inc (NASDAQ:AXDX) major shareholder Larry N. Feinberg purchased 11,835 shares of the company’sstock on the open market in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average price of $15.92 per share, with a total value of $188,413.20. Following the acquisition, the insider now directly owns 14,256 shares in the company, valued at approximately $226,956.
Equities research analysts at RBC Capital assumed coverage on shares of Mobileye NV (NASDAQ:MBLY) in a research note issued to investors on Wednesday, The firm set an “outperform” rating and a $43.00 price target on the stock. RBC Capital’s target price would suggest a potential upside of 33.75% from the stock’s previous close.
I expected an improvement in margin instead drop...not good future prospects here...time to move on
Accelerate Diagnostics (NASDAQ:AXDX) Director Matthew Strobeck purchased 20,000 shares of the stock in a transaction dated Tuesday, August 5th. The shares were purchased at an average cost of $16.70 per share, with a total value of $334,000.00.
Accelerate Diagnostics (NASDAQ:AXDX) major shareholder Larry N. Feinberg purchased 11,835 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average price of $15.92 per share, with a total value of $188,413.20.
Resonant Inc. (NASDAQ:RESN) (“Resonant” or “the Company”) announced that it has been added as a member of the Russell Microcap® Index after the equity markets closed on June 27, which is when Russell Investments reconstituted its comprehensive family of global indexes. Company has 40.50% insider ownership.
Goldman Sachs, Nomura and Stifel all initiated coverage on shares of MobileIron, Inc. (NASDAQ:MOBL) with “Buy” ratings. Morgan Stanley and Barclays also initiated coverage on the stock with “Overweight” ratings